The Keynote Address, entitled "Beyond Ketamine: Combined Interventional Treatment of Suicidal Depression and PTSD," will be presented at 10:30AM PT on Sunday January 12th, 2025 Prof. David Feifel MD PHD, designated Chief Medical Innovation Officer of HOPE and Founder of the Kadima...
Read More Details
Finally We wish PressBee provided you with enough information of ( HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTS )
Also on site :
- Ednetics Joins Forces with MGT to Enhance Technology Solutions for Education and Government Sectors
- Bruno Wehbe: Westfield partnership will transform Cenomi malls into world-class lifestyle destinations
- The Future of Manufacturing Might Be in Space